TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock Börse Stuttgart
Equities
2TZ
CNE100000924
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.3 EUR | +4.95% |
|
+12.27% | +26.81% |
| May. 15 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Directorate and Committee Changes | CI |
| Apr. 30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
| Sales 2024 * | 9.05B 1.25B 1.15B | Sales 2025 * | 9.96B 1.38B 1.27B | Capitalization | 23.73B 3.28B 3.02B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.17B 162M 149M | Net income 2025 * | 1.4B 193M 178M | EV / Sales 2024 * | 2.62 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.38 x |
| P/E ratio 2024 * |
23.1
x | P/E ratio 2025 * |
19.4
x | Employees | 4,619 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.14% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.95% | ||
| 1 week | +12.27% | ||
| Current month | +19.12% | ||
| 1 month | +26.54% | ||
| 3 months | +34.83% | ||
| 6 months | +26.90% | ||
| Current year | +26.81% |
1 week
1.98
2.30
1 month
1.822.30
Current year
1.522.30
1 year
1.522.30
3 years
0.762.30
5 years
0.442.30
10 years
0.442.30
| Managers | Title | Age | Since |
|---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-21 |
Jian Ma
DFI | Director of Finance/CFO | 46 | 23-07-20 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guat Kwang Yeo
BRD | Director/Board Member | 63 | Nov. 27 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 20-06-04 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 2.3 | +4.95% |
| 24-05-23 | 2.192 | +10.86% |
| 24-05-22 | 1.977 | -6.91% |
| 24-05-21 | 2.124 | +0.21% |
| 24-05-20 | 2.12 | +3.44% |
Delayed Quote Börse Stuttgart, May 24, 2024 at 02:04 am EDT
More quotes
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.
Sector
Pharmaceuticals
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
35.16
CNY
Average target price
45.8
CNY
Spread / Average Target
+30.26%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +37.65% | 6.04B | |
| -19.68% | 4.27B | |
| -15.69% | 2.96B | |
| -5.64% | 2.43B | |
| +44.89% | 1.93B | |
| -12.71% | 1.59B | |
| -4.27% | 1.58B | |
| -14.86% | 1.5B | |
| +42.40% | 1.47B |
- Stock Market
- Equities
- 600329 Stock
- 2TZ Stock
